69 related articles for article (PubMed ID: 25663359)
1. On relevant features for the recurrence prediction of urothelial carcinoma of the bladder.
Schwarz L; Sobania D; Rothlauf F
Int J Med Inform; 2024 Jun; 186():105414. PubMed ID: 38531255
[TBL] [Abstract][Full Text] [Related]
2. A Novel Decision Tree Model for Predicting the Cancer-Specific Survival of Patients with Bladder Cancer Treated with Radical Cystectomy.
Sarrio-Sanz P; Martinez-Cayuelas L; Beltran-Perez A; Muñoz-Montoya M; Segura-Heras JV; Gil-Guillen VF; Gomez-Perez L
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673449
[No Abstract] [Full Text] [Related]
3. Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy--A Prospective Multicenter Study.
Martini T; Aziz A; Roghmann F; Rink M; Chun FK; Fisch M; Trojan L; Hakenberg OW; Zastrow S; Wirth MP; Moersdorf J; Brookman-May S; Stief CG; Haferkamp A; Wagenlehner F; Hohenfellner M; Herrmann E; Lusuardi L; Grimm MO; Müller SC; Roigas J; Bastian PJ; Gierth M; Burger M; Pycha A; Seitz C; May M; Bolenz C
Urol Int; 2016; 96(1):57-64. PubMed ID: 26139354
[TBL] [Abstract][Full Text] [Related]
4. Perioperative therapy in muscle invasive bladder cancer.
Chatterjee A; Bakshi G; Pal M; Kapoor A; Joshi A; Prakash G
Indian J Urol; 2021; 37(3):226-233. PubMed ID: 34465951
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View.
Kim HJ; Chun J; Kim TH; Yang G; Shin SJ; Kim JS; Yang J; Ham WS; Koom WS
Yonsei Med J; 2021 Jul; 62(7):569-576. PubMed ID: 34164953
[TBL] [Abstract][Full Text] [Related]
6. Supplementary granulocyte macrophage colony-stimulating factor to chemotherapy and programmed death-ligand 1 blockade decreases local recurrence after surgery in bladder cancer.
Miyake M; Hori S; Ohnishi S; Toritsuka M; Fujii T; Shimizu T; Owari T; Morizawa Y; Gotoh D; Itami Y; Nakai Y; Anai S; Torimoto K; Tanaka N; Fujimoto K
Cancer Sci; 2019 Oct; 110(10):3315-3327. PubMed ID: 31385407
[TBL] [Abstract][Full Text] [Related]
7. Trimodality therapy for bladder cancer: modern management and future directions.
Pham A; Ballas LK
Curr Opin Urol; 2019 May; 29(3):210-215. PubMed ID: 30855374
[TBL] [Abstract][Full Text] [Related]
8. Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
Necchi A; Pond GR; Moschini M; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Vaishampayan U; Theodore C; Sridhar SS; Rosenberg JE; Bellmunt J; Gallina A; Colombo R; Montorsi F; Briganti A; Galsky MD
Clin Genitourin Cancer; 2019 Feb; 17(1):7-14.e3. PubMed ID: 30292628
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy.
Sargos P; Baumann BC; Eapen L; Christodouleas J; Bahl A; Murthy V; Efstathiou J; Fonteyne V; Ballas L; Zaghloul M; Roubaud G; Orré M; Larré S
Cancer Treat Rev; 2018 Nov; 70():88-97. PubMed ID: 30125800
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial.
Zaghloul MS; Christodouleas JP; Smith A; Abdallah A; William H; Khaled HM; Hwang WT; Baumann BC
JAMA Surg; 2018 Jan; 153(1):e174591. PubMed ID: 29188298
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?
Chua KLM; Kusumawidjaja G; Murgic J; Chua MLK
ESMO Open; 2016; 1(6):e000123. PubMed ID: 28848661
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
Orré M; Latorzeff I; Fléchon A; Roubaud G; Brouste V; Gaston R; Piéchaud T; Richaud P; Chapet O; Sargos P
PLoS One; 2017; 12(4):e0174978. PubMed ID: 28384195
[TBL] [Abstract][Full Text] [Related]
13. Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patients.
Furudoï A; Varinot J; Phe V; Roupret M; Bitker MO; Compérat E
Virchows Arch; 2017 May; 470(5):561-565. PubMed ID: 28280928
[TBL] [Abstract][Full Text] [Related]
14. The Rationale for Post-Operative Radiation in Localized Bladder Cancer.
Baumann BC; Sargos P; Eapen LJ; Efstathiou JA; Choudhury A; Bahl A; Murthy V; Ballas LK; Fonteyne V; Richaud PM; Zaghloul MS; Christodouleas JP
Bladder Cancer; 2017 Jan; 3(1):19-30. PubMed ID: 28149931
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radiotherapy for pathological high-risk muscle invasive bladder cancer: time to reconsider?
Sargos P; Baumann BC; Eapen LJ; Bahl A; Murthy V; Roubaud G; Orré M; Efstathiou JA; Shariat S; Larré S; Richaud P; Christodouleas JP
Transl Androl Urol; 2016 Oct; 5(5):702-710. PubMed ID: 27785427
[TBL] [Abstract][Full Text] [Related]
16. Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.
Aziz A; Gierth M; Rink M; Schmid M; Chun FK; Dahlem R; Roghmann F; Palisaar RJ; Noldus J; Ellinger J; Müller SC; Pycha A; Martini T; Bolenz C; Moritz R; Herrmann E; Keck B; Wullich B; Mayr R; Fritsche HM; Burger M; Bastian PJ; Seitz C; Brookman-May S; Xylinas E; Shariat SF; Fisch M; May M;
World J Urol; 2015 Dec; 33(12):1945-50. PubMed ID: 25947885
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
Novotny V; Froehner M; May M; Protzel C; Hergenröther K; Rink M; Chun FK; Fisch M; Roghmann F; Palisaar RJ; Noldus J; Gierth M; Fritsche HM; Burger M; Sikic D; Keck B; Wullich B; Nuhn P; Buchner A; Stief CG; Vallo S; Bartsch G; Haferkamp A; Bastian PJ; Hakenberg OW; Propping S; Aziz A
World J Urol; 2015 Nov; 33(11):1753-61. PubMed ID: 25663359
[TBL] [Abstract][Full Text] [Related]
18. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
19. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
